Cladribine Injection

Cladribine Injection Specification

Dosage Form
Injection

Indication
Treatment of certain types of leukemia including hairy cell leukemia

Salt Composition
Cladribine

Enzyme Types
Nucleoside analogue

Feature
Ready-to-use sterile injection

Ingredients
Cladribine (active), sterile water for injection

Application
Antineoplastic therapy

Ph Level
Neutral (pH 4.5-7.0)

Physical Color/Texture
Clear, colorless solution

Fermentation Smell
Odorless

Enzymatic Activity
Acts by inhibiting DNA synthesis in leukemic cells

Storage Instructions
Store at 2°C to 8°C (refrigerated), protect from light

Shelf Life
24 months (unopened vial)

Route of Administration
Intravenous (IV) infusion

Disposal Information
Dispose of vial as per hospital biohazard protocol

Batch Number Reference
Printed on vial label

Clinical Efficacy
Demonstrated remission in hairy cell leukemia

Strength
10 mg/ml

Prescription Status
Prescription only

Volume
1 ml and 5 ml vials available

Manufacturing Standard
GMP Certified

Marketed By
Available through hospital pharmacies

Usage Instructions
Administer under supervision of qualified health personnel

Sterility
Sterile

Packaging Type
Glass vial

Contraindications
Pregnancy, Hypersensitivity to cladribine

Registration
FDA/EMA approved

Cladribine Injection Trade Information

Minimum Order Quantity
100 Bottles

FOB Port
FOB Port

Payment Terms
Telegraphic Transfer (T/T), Cash in Advance (CID)

Supply Ability
1000 Bottles Per Week

Delivery Time
1 Week

Sample Available
Yes

Sample Policy
Free samples available with shipping and taxes paid by the buyer

Main Export Market(s)
Western Europe, Australia, North America, Eastern Europe, Central America, Middle East, South America, Asia, Africa

Certifications
MSME

Cladribine Injection About

Cladribine Injection

Cladribine is a prescribed Cancer drug that is used to treat hairy cell leukemia (a type of blood cancer). To buy 'Cladribine Injection' or to know its price contact India's leading Wholesaler and Exporter 3S Corporation.

Clinically Proven Leukemia Therapy

Cladribine Injection demonstrates significant remission rates for patients with hairy cell leukemia as confirmed in clinical studies. Its nucleoside analogue action inhibits DNA synthesis in leukemic cells, helping to control disease progression. The treatment is intended for use in hospital settings and prescribed by medical professionals, ensuring the highest standard of care for individuals undergoing antineoplastic therapy.

Strict Safety and Administration Guidelines

This product requires intravenous administration by qualified healthcare personnel and is available only via prescription. Contraindicated in pregnancy and those with hypersensitivity to cladribine, the injection must be stored at 2C to 8C and protected from light. Dispose of used vials according to hospital biohazard protocols to ensure safety and compliance with medical standards.

High-Quality, Ready-to-Use Solution

Packaged in sterile glass vials, each batch of Cladribine Injection is GMP certified and clearly labeled for traceability. The solution is odorless, clear, and colorless, with a neutral pH, providing a safe and effective option for intravenous therapy. Shelf life extends to 24 months (unopened), simplifying inventory management for hospital pharmacies and dealers.

FAQ's of Cladribine Injection:

Q: How should Cladribine Injection be administered to patients?

A: Cladribine Injection must be administered intravenously under the supervision of qualified health personnel in a hospital setting, following the recommended dosage and infusion protocol specified by a physician.

Q: What indications support the use of Cladribine Injection?

A: It is prescribed for the treatment of certain types of leukemia, such as hairy cell leukemia, due to its demonstrated ability to induce remission in affected patients.

Q: When and where is Cladribine Injection available for purchase or use?

A: This injection is available exclusively through hospital pharmacies in India and must be prescribed by a licensed healthcare provider.

Q: What storage conditions are essential for maintaining Cladribine Injection's potency?

A: To retain efficacy and shelf life, store unopened vials at 2C to 8C (refrigerated) and protect them from light.

Q: What is the proper method for disposing of used Cladribine Injection vials?

A: After use, vials should be disposed of according to the hospital's biohazard waste protocols, ensuring safe and compliant handling of medical waste.

Q: Why is Cladribine Injection contraindicated for certain patients?

A: Use is contraindicated in individuals who are pregnant or have known hypersensitivity to cladribine, as exposure may lead to adverse effects or increase health risks.

Q: What are the key ingredients in Cladribine Injection and how do they work?

A: The injection contains cladribine as the active ingredient and sterile water for injection; cladribine acts by inhibiting DNA synthesis in leukemic cells, disrupting their ability to multiply.